Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
QGEN [NASD]
Qiagen NV
Index- P/E37.30 EPS (ttm)0.50 Insider Own- Shs Outstand238.98M Perf Week-0.69%
Market Cap4.46B Forward P/E17.59 EPS next Y1.06 Insider Trans- Shs Float236.64M Perf Month-6.61%
Income120.90M PEG3.44 EPS next Q0.24 Inst Own- Short Float1.55% Perf Quarter-15.15%
Sales1.26B P/S3.53 EPS this Y33.91% Inst Trans- Short Ratio4.32 Perf Half Y7.06%
Book/sh11.45 P/B1.63 EPS next Y7.07% ROA3.09% Target Price20.90 Perf Year10.36%
Cash/sh1.93 P/C9.68 EPS next 5Y10.83% ROE4.56% 52W Range15.66 - 22.20 Perf YTD2.75%
Dividend- P/FCF29.31 EPS past 5Y13.56% ROI3.42% 52W High-15.99% Beta0.74
Dividend %- Quick Ratio3.17 Sales past 5Y14.06% Gross Margin66.16% 52W Low19.09% ATR0.40
Employees3999 Current Ratio3.66 Sales Q/Q2.41% Oper. Margin12.87% RSI (14)35.84 Volatility1.21% 1.71%
OptionableYes Debt/Eq0.32 EPS Q/Q-30.85% Profit Margin9.60% Rel Volume1.00 Prev Close18.60
ShortableYes LT Debt/Eq0.32 EarningsJul 24 AMC Payout0.00% Avg Volume847.72K Price18.65
Recom3.00 SMA20-4.56% SMA50-7.82% SMA200-2.28% Volume845,208 Change0.27%
01-May-13Downgrade Barclays Overweight → Equal Weight $21 → $19
30-Apr-13Reiterated ISI Group Neutral $22.50 → $21
30-Jan-13Reiterated Mizuho Neutral $17 → $19
28-Jan-13Reiterated Barclays Overweight $18 → $21
11-Oct-12Downgrade HSBC Securities Neutral → Underweight
26-Apr-12Reiterated Mizuho Neutral $15 → $17
17-Oct-11Reiterated Barclays Capital Overweight $21 → $15
25-Jul-11Downgrade Wedbush Outperform → Neutral $24 → $19
13-Apr-11Initiated HSBC Securities Neutral
31-Mar-11Downgrade GARP Research Buy → Neutral
15-Nov-10Reiterated RBC Capital Mkts Sector Perform $20 → $18
21-Apr-10Initiated RBC Capital Mkts Underperform
07-Oct-09Initiated Barclays Capital Overweight $24
10-Jul-09Downgrade UBS Buy → Neutral
11-Mar-09Initiated Wedbush Morgan Buy $25
03-Mar-09Initiated Jefferies & Co Buy
12-Feb-09Downgrade Credit Suisse Outperform → Neutral
17-Sep-08Initiated Leerink Swann Mkt Perform
11-Oct-07Initiated Piper Jaffray Outperform $24
22-Mar-07Upgrade Deutsche Securities Hold → Buy
15-May-13 04:50PM  Qiagen Moves Up In Market Cap Rank, Passing Avery Dennison at Forbes
07:00AM  QIAGEN Posts 2012 Annual Report on Its Website GlobeNewswire
03:56AM  Roche Wins FDA Approval for Test to Target Lung Cancer at Bloomberg
14-May-13 05:27PM  Roche Wins FDA Approval for Test to Target Lung Cancer at Bloomberg
10-May-13 04:24PM  Short Interest In Qiagen Decreases By 13.8% at Forbes
09-May-13 05:14AM  Qiagen: Limited Visibility On When Improvement Will Materialize at Seeking Alpha
08-May-13 11:55AM  Recent Financials May Not Be Entirely Fair To Hologic at Investopedia
01-May-13 04:32PM  QGEN Makes Notable Cross Below Critical Moving Average at TheStreet
08:50AM  Qiagen Misses Earnings, Guides Low Zacks
07:23AM  The Zacks Analyst Blog Highlights: LinkedIn, AOL, Facebook, Paychex and Qiagen Zacks
30-Apr-13 03:20PM  Qiagen NV Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
01:50PM  Qiagen Acquires IngenuitySystems Zacks
29-Apr-13 05:19PM  Qiagen Earnings: Heres Why Investors Dont Like These Results at Wall St. Cheat Sheet
04:05PM  QIAGEN Proposes Changes to Members of Supervisory Board PR Newswire
04:02PM  InPlay: Qiagen acquires Ingenuity Systems, a provider of software solutions to analyze and interpret the biological meaning of genomic data, for $105 mln in cash Briefing.com
04:00PM  QIAGEN Reports First Quarter 2013 Results PR Newswire
04:00PM  QIAGEN Acquires Ingenuity Systems, Adding Leading Solution for Analysis and Interpretation of Complex Biological Data PR Newswire
28-Apr-13 01:07PM  Qiagen Nv Earnings Preview: Get Ahead of the Analysts at Wall St. Cheat Sheet
15-Apr-13 06:03AM  QIAGEN N.V. to Report First Quarter 2013 Results and Hold Webcast GlobeNewswire
02-Apr-13 03:15AM  Trovagene Advances Next-Gen Version Of Qiagen's HPV Test at Seeking Alpha
28-Mar-13 02:08PM  QIAGEN Extends Portfolio Zacks
27-Mar-13 02:30AM  New DNA Test Cuts Time to Find Horsemeat in Food from Two Days to Less than Four Hours PR Newswire
25-Mar-13 04:21PM  Atossa Genetics: Room For Further Price Appreciation at Seeking Alpha
01:02AM  This Metric Suggests You're Right to Own Qiagen. at Motley Fool
07-Mar-13 01:04PM  QIAGEN NV Financials EDGAR Online Financials
01-Mar-13 12:04PM  4 Stocks Pushing The Diversified Services Industry Lower at TheStreet
26-Feb-13 09:13AM  LipoScience - A Small Company Targeting A Large Market at Seeking Alpha
20-Feb-13 04:00PM  QIAGEN Unveils Sample-to-Result Next-Generation Sequencing Workflow Designed for Clinical Research and Diagnostics PR Newswire
15-Feb-13 01:48PM  Qiagen in Collaboration with Lilly Zacks
13-Feb-13 05:34PM  Qiagen and Lilly expand diagnostic partnership AP
04:02PM  InPlay: Qiagen enters into broad collaboration agreement with Lilly (LLY) for the development and commercialization of companion diagnostics Briefing.com
04:00PM  QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics PR Newswire
12-Feb-13 04:58PM  Qiagen N.V. Moves Up In Market Cap Rank, Passing AGL Resources at Forbes
07-Feb-13 06:48PM  Halftime Report: Q4 Earnings Season at Seeking Alpha
04-Feb-13 11:57AM  Stowaway Killer TB Travels Globe Fueling Screening Sales at Bloomberg
04:30AM  Stowaway Killer TB Travels Globe Fueling Screening Sales at Bloomberg
03-Feb-13 06:01PM  Stowaway Killer TB Travels Globe Fueling Screening Sales at Bloomberg
31-Jan-13 10:04AM  Yum! Improves SSS in China and 4 Stock Analyses Making Rounds at Wall St. Cheat Sheet
09:18AM  Qiagen Beats on Both Top and Bottom Lines at Motley Fool
30-Jan-13 03:46PM  QIAGEN's CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha +6.11%
01:15PM  Qiagen Rises as Profit Forecast Tops Estimates at Bloomberg
05:28AM  QIAGEN's KRAS companion diagnostic kit adopted by GE Healthcare's Clarient theflyonthewall.com
05:17AM  Qiagen Rises as Profit Forecast Beats Estimates: Frankfurt Mover at Bloomberg
01:00AM  QIAGEN's KRAS Companion Diagnostic for Colorectal Cancer Adopted by Clarient, a Leading U.S. Oncology Service Lab PR Newswire
29-Jan-13 04:06PM  InPlay: Qiagen beats by $0.03, beats on revs; guides FY13 EPS above consensus Briefing.com
04:00PM  QIAGEN Reports Fourth Quarter and Full-Year 2012 Results PR Newswire
25-Jan-13 09:10AM  Qiagen Earnings Are on Deck at Motley Fool
24-Jan-13 05:48PM  Medtronic Ends SFA II Enrollment Zacks
18-Jan-13 04:28PM  Qiagen Seeks FDA Approval Zacks
16-Jan-13 02:18PM  FDA Categorizes Cepheid's New Test Zacks
15-Jan-13 12:28PM  Hologic Widens Diagnostic Biz Zacks
08:18AM  Qiagen Beats 2012 Placement Target Zacks
08:14AM  QIAGEN N.V. to Report Fourth Quarter and Full-Year 2012 Results and Hold Webcast GlobeNewswire
08:03AM  InPlay: Qiagen submits companion diagnostic to FDA to guide treatment decisions for new investigational lung cancer compound Briefing.com
08:00AM  QIAGEN Submits Companion Diagnostic to FDA to Guide Treatment Decisions for New Investigational Lung Cancer Compound PR Newswire
10-Jan-13 02:28PM  QIAGEN Inks Three New Deals Zacks
08-Jan-13 09:26AM  Gates, Milner Back Cancer-Genetics Startup at Bloomberg
09:26AM  Gates, Milner Back Cancer Genetics Startup Foundation Medicine at Bloomberg
07-Jan-13 07:56PM  IntelligentMDx Enters into an Agreement with QIAGEN to Develop and Manufacture Molecular Tests PR Newswire
04:01PM  InPlay: Qiagen announces three agreements with biomakers for development pipeline of diagnostics for Personalized Healthcare applications; enters into agreement with IMDx to develop molecular tests Briefing.com
04:00PM  QIAGEN Exceeds 2012 Goal for Placements of QIAsymphony Breakthrough Laboratory Automation System PR Newswire
04:00PM  QIAGEN Adds to Pipeline of Personalized Healthcare Diagnostics Through Agreements for Promising New Biomarkers PR Newswire
04:00PM  IMDx Enters into an Agreement with QIAGEN to Develop Molecular Tests PR Newswire
04-Jan-13 11:48AM  Hologic to Divest LIFECODES Biz Zacks
10:00AM  QIAGEN to Present at the 31st Annual J.P. Morgan Healthcare Conference GlobeNewswire
16-Dec-12 12:02PM  4 Stories to Watch This Week in the Health-Care Sector at Motley Fool
10-Dec-12 04:08AM  Qiagen NV Stock Downgraded (QGEN) at TheStreet
02-Dec-12 04:56AM  Week In Review: Hutchison Chi-Med Forms Drug Development JV With NestlĂ© at Seeking Alpha
28-Nov-12 05:06PM  Here's How Qiagen Is Making You So Much Cash at Motley Fool
04:02PM  InPlay: Qiagen gains SFDA approval to market careHPV test in China Briefing.com
04:00PM  QIAGEN Gains SFDA Approval to Market careHPV Test in China - Expanding Access to HPV Testing in Low-resource Countries PR Newswire
25-Nov-12 01:14AM  This Metric Says You're Smart to Own Qiagen at Motley Fool
14-Nov-12 08:23PM  1 Reason to Expect Big Things from Qiagen at Motley Fool
09:39AM  Hologic Surpasses Estimates Zacks
08-Nov-12 01:10PM  Golf Clap for Qiagen at Motley Fool
06-Nov-12 01:08PM  Golf Clap for Qiagen at Motley Fool
10:09AM  Qiagen Misses on EPS, Revs Beat Zacks
05-Nov-12 02:37PM  Qiagen N.V's CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
01:49PM  Will It Be Even Harder For Life Tech To Muddle Through In 2013? at Investopedia
01:41PM  5 Stocks Pushing The Diversified Services Industry Higher at TheStreet
12:30PM  QIAGEN Kicks Off Next-Generation Sequencing Initiative With Launch of a Series of Consumable Products to Improve NGS Workflows PR Newswire
04-Nov-12 08:47AM  QIAGEN Reports Third Quarter 2012 Results PR Newswire
30-Oct-12 06:21AM  InPlay: Qiagen reschedules earnings to Sunday night (November 4) Briefing.com
05:43AM  QIAGEN N.V. Reschedules Publication of Q3 2012 Results Due to Severe U.S. Weather Conditions GlobeNewswire
27-Oct-12 02:18AM  Can Qiagen Beat These Numbers? at Motley Fool
25-Oct-12 02:30AM  QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies PR Newswire
17-Oct-12 05:34PM  Hologic Grows Diagnostics Portfolio Zacks
16-Oct-12 08:31AM  QIAGEN N.V. to Report Third Quarter 2012 Results and Hold Webcast GlobeNewswire
10-Oct-12 08:54PM  Qiagen downgraded by HSBC Securities Briefing.com
07-Oct-12 02:36PM  Heres Why Morgan Stanley Rated Hologic Outperform at Wall St. Cheat Sheet
04-Oct-12 12:36AM  Heres Why Morgan Stanley Rated Hologic Outperform at Wall St. Cheat Sheet
03-Oct-12 04:47PM  Heres Why Morgan Stanley Rated Hologic Outperform at Wall St. Cheat Sheet
29-Sep-12 04:09AM  Qiagen: Downside Priced In, CDx And Automation Upside, Undervalued Compared To Peers at Seeking Alpha
27-Sep-12 07:01AM  Europe Stocks Rally Will Continue, Manning & Napier Says at Bloomberg
21-Sep-12 04:00PM  Disclosure According to Art. 4 Para. 2 of the Regulation (EC) No. 2273/2003 PR Newswire
20-Sep-12 01:08PM  Affordable Care Act (ACA) is No Longer an Issue for Biotech Stock Valuations: Interview with UBS Investment Bank Expert Analyst Wall Street Transcript
01:05PM  Developments in Hepatitis C, HIV, Rheumatoid Arthritis Therapies Propel Growth in Biotech: Interview with UBS Investment Bank Expert Analyst Wall Street Transcript
17-Sep-12 04:54PM  Qiagen's Point of Need in China Zacks
14-Sep-12 03:28PM  Earnings Analysis For Pall Corp.: Sustainable Returns Relative To Peers at Seeking Alpha
08:50AM  Why Qiagen May Be About to Take Off at Motley Fool
QIAGEN N.V., through its subsidiaries, provides sample and assay technologies worldwide. It offers approximately 500 core consumable products, such as sample and assay kits, and automated instrumentation systems that empower customers to transform raw biological samples into molecular information. The company's consumable products are used for plasmid deoxyribonucleic acid (DNA) purification, and ribonucleic acid purification and stabilization; genomic and viral nucleic acid purification; nucleic acid transfection; polymerase chain reaction (PCR) amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. The company sells the digene HC2 HPV Test, a signal-amplified test for high-risk strains of the human papillomavirus. It also offers co-development services for companion diagnostics, technology licensing and patent sales services, and custom services, including whole genome amplification, DNA sequencing, and non-cGMP DNA production on a contract basis. The company's instrumentation systems automate the use of sample and assay technologies into solutions for a range of laboratory needs enabling customers to perform nucleic acid sample preparation, assay setup, target detection, and other laboratory tasks. Its automated systems include QIAsymphony, a modular system; Rotor-Gene Q, a rotary real-time PCR cycler system; PyroMark, a high-resolution detection platform based upon the Pyrosequencing technology; QIAcube, a sample processing instrument; QIAxcel for nucleic acid separation in low- to high-throughput laboratories; and ESE-Quant Tube Scanners, an optical measurement device. The company serves customer classes, including molecular diagnostics laboratories; applied testing customers in fields, such as forensics, veterinary diagnostics, and food safety; pharmaceutical research and development groups, and academic researchers. QIAGEN N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands.